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> A JEWEL
IN THE

I Gray Map

A four-year study at the Institute will help to identify and treat
patients who are at risk of bone loss in the upper and lower
jaws. These histograms and color-enhanced images distinguish
between healthy peridontal bone (depicted as a normal bellshaped curve and a homogeneous distribution of color levels)
and bone resorption (distortion in plot curve and extreme variance in brightness levels). For more information, turn to page 6.
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.A WOMAN'S HEALTH ISSUE
The combination of aerospace technology and digital
imaging may help to establish a link between osteoporosis
and peridontal bone loss in postmenopausal women.
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Positron emission tomography and a man-made version
of one of the body's proteins offer a bright spot in the
diagnosis and treatment of prostate cancer.

IMAGING CENTER
Construction of the Institute's research center moves
steadily toward its scheduled mid-1994 completion date.
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Just as some breast cancer cells are receptive to the hormone estrogen,
prostate cancer cells may carry receptors for somatostatin, a natural
protein. In her lab at Mallinckrodt Institute, Dr. Carolyn Anderson hopes

MALLINCKRODT
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to synthesize somatostatin for use in prostate cancer research.
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Photograph by T. Mike Fletcher.

SPOT NEWS
William E. Powers, M.D.,

Powers
Delivers
Probstein
Lecture
After a 15-year absence
from the Institute, William E.
Powers, M.D., a recognized
authority in treatment techniques for carcinoma of the
uterine cervix and preoperative radiation therapy for
head-and-neck tumors, presented the Probstein Oncology Lecture on September 10.
Speaking on "Bone Metastases: Fallacies, Dogma, and
Reason," Powers peppered his
talk with witty observations
(including a suggested list of
little known punctuations and
terms for use in scientific
papers) while driving home
the clinical facts about bone
metastases.
Powers pointed out that
bone metastases occur in
100,000 new patients each
year. At least one-fifth of
patients who die of cancer

experience clinical bone
metastases, and one-third of
those patients develop fractures or cord compression that
produce massive dysfunction.
He believes that radiation therapy is the least expensive and
most effective local
chemotherapeutic agent
known, and that any patient
with clinical lesion metastases
should be treated concurrently
to systemic therapy with local
high dose radiation therapy.
Powers, a 1993 recipient
of the prestigious Gold Medal
Award presented by the American College of Radiology, is a
former director of the MIR
Radiation Oncology Center.
In the late 1960s, while on staff
at the Institute, he recognized
the necessity of shielding surrounding normal tissue from
the high doses of radiation
required to destroy tumors.
His design for blocks made of
an alloy called Cerrobend is
used in radiation oncology centers nationwide. In 1965, working with Washington University
computer scientists, Powers
was instrumental in developing
a computer system dedicated
to radiation treatment planning. In 1978, he was
appointed chairman of the
Department of Radiation
Oncology at Wayne State
University School of Medicine
in Detroit.
The Probstein Oncology
Lecture was established in
1985 in honor of Carlos A.
Perez, M.D., director of the
MIR Radiation Oncology Center, and William Fair, M.D.,
former head of urology in
Washington University's
Department of Surgery.

Forman Earns
Unprecedented
Clinical
Scholarship
As the first MIR recipient of the Robert Wood
Johnson Clinical Scholarship, Howard Forman, M.D.,
fourth-year resident in diagnostic radiology, will begin
health services research in
1994 at the University of
Pennsylvania's Wharton
School of Business.
The scholarship is an
unusual honor for a radiologist. During its 20-year history, past recipients have
generally been clinicians, a
number of whom have gone
on to chair internal medicine
departments at top U.S. medical centers. Many of the
physicians who are members
of First Lady Hillary Rodham
Clinton's Task Force for
Health Care Reform also
received the award. The
scholarship is sponsored by
the Robert Wood Johnson
Foundation, the United
States' largest privatelyfunded health-care research
foundation.
During his two-year program, Forman will focus his
studies on the technology
assessment and cost-effectiveness of health care.
According to Forman, "In
order to have an excellent
health-care program, you not
only need the technology
and science but also the ability to deliver the health
care."

ACR/MIR:
The Tradition
Continues
At the American College
of Radiology (ACR) Annual
Meeting in September, three
MIR faculty members stood
among the 112 outstanding
clinicians and scientists
nationwide who were designated as ACR fellows:
Venkata R. Devineni, M.D.;
Joseph R. Simpson, Ph.D.,
M.D.; and Michael W. Vannier, M.D. The ACR annually
recognizes those radiologists,
radiation oncologists, and
radiological physicists who
make significant scientific or
clinical research contributions or literary contributions
in the field of radiology.
Devineni, an associate
professor of radiology, Radiation Oncology Center, is clinical chief of radiation oncology at DePaul Hospital. He
was chief resident during his
training at Emory University
and completed a fellowship at
the Institute. Since joining the
MIR faculty in 1980, Devineni's primary interest has
been in clinical radiation
oncology, specifically headand-neck oncology.
Simpson, an associate
professor of radiology, Radiation Oncology Center, joined
the MIR faculty in 1978 after
completing a residency in
radiation oncology at the University of Wisconsin Hospital,
Madison. During his training,
he was chief resident, 1977 to
1978, and was named an
American Cancer Society
Clinical Fellow. At the Institute, Simpson has focused his
research on treatment techniques of central nervous system tumors, including
stereotactic external beam
irradiation and 3-D treatment
planning.
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Vannier, professor of
radiology, director of the
Hti Division of Radiology
Research, is a pioneer in the
clinical application of 3-D
imaging. He works closely
with surgical collaborators to
isJ identify and develop comrf.HH, puter aids for diagnosis and
treatment. After completing
,„,: a residency in diagnostic radias )| ology at MIR, Vannier joined
the faculty in 1982.
An additional honor for
ilii: the Institute is the renaming
% 1 of MIR Director Ronald G.
i.»7 Evens, M.D., as secretary-treasurer of the ACR Board of
Chancellors. Evens, a recogstfsi nized authority in the socioeconomics of medicine, was
i: [i«
first named to the ACR Board
A in 1988. The 24-member
Board is the governing body
of the ACR, determining pol. ;•;:
icy standards for this national
organization of more than
28,000 radiologists.
■:;,:•>;■

Mirowitz
'& Appointed Chief

»!*.,
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In January of 1994, Scott
A. Mirowitz, M.D., director of
Jewish Hospital's magnetic
resonance imaging section,
will assume the responsibilities of radiologist-in-chief of
the Institute's radiology
department at Jewish
Hospital. The appointment
followed a six-month national
search led by committee
cochairs Ronald G. Evens,
M.D., MIR director, and
Wayne M. Lerner, DPH, president and senior executive officer of Jewish Hospital.
With this new alignment,
the Institute will coordinate
all radiologic services within
Washington University Medical
Center and at Barnes West in
St. Louis County. According to
Evens, Mirowitz will have an
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excellent opportunity to
develop a nationally recognized academic department
while maintaining Jewish
Hospital's long-standing tradition of providing excellent clinical service. Lerner believes
the cooperative effort will further the roles of the Institute,
Washington University, and
Jewish Hospital as regional
healthcare leaders and institutes for scientific inquiry.
Mirowitz has an outstanding reputation as a physician
and a scientist. Under his
leadership, Jewish Hospital's
magnetic resonance imaging
(MRI) section reported an 80
percent growth rate over the
past three and one-half years
while providing quality service
to patients and physicians. An
alumnus of Washington University School of Medicine,
Mirowitz completed four
years of training in diagnostic
radiology through the MIR/
Jewish Hospital-affiliated residency program and a one-year
fellowship in magnetic resonance imaging.

Scott A. Mirowitz, M.D.

Barbara Monsees, M.D.

Monsees
Heads Breast
Imaging
Section
In recognition of the
important role that mammography continues to play
in women's health care, Barbara Monsees, M.D., was
named chief of breast imaging, a new section under the
Division of Diagnostic Radiology. As a member of the
MIR team who, in 1986,
brought the first mobile
mammography van to the St.
Louis region, Monsees is an
effective advocate of the
benefits of early detection of
breast cancer through
screening.
Monsees, who joined
the MIR faculty in 1980, and
a team of researchers hold
the patent for a radiologically compatible filler for
breast implants. She was
instrumental in developing
the new Mammography
Screening Center at Barnes
Hospital. The Center's location on the first floor of the
hospital offers women convenient access to routine
mammography screening.

McClennan on
Advisory
Board
The Board of Directors
of the Radiological Society
of North America (RSNA)
appointed Bruce L. McClennan, M.D., professor of radiology and chief of MIR's
abdominal imaging section,
to serve on the 1994 Public
Information Advisory Board.
As a board member, McClennan, an expert in the assessment of radioiodinated
contrast agents and in genitourinary radiological
research, will review
abstracts and help select
papers and scientific
exhibits featured at the
annual RSNA symposium.
Throughout the year,
board members also serve as
informational resources for
the news media. Acknowledged as experts in scientific
research, these physicians
are often called upon by the
American Medical Association (AMA) for clarification
of data in reports issued by
the AMA's Council on Scientific Affairs. This information is frequently published
in specialty medical journals
and quoted in news articles
on health-related issues.

SPOT NEWS
Slone Trained
in Medical
Journalism

C. Douglas Maynard, M.D.
(left); Mrs. Wendell Scotland Ronald G. Evens, M.D.

Important
Issues in
Radiology
"There are those who say
that the golden age of radiology is past. Don't believe it.
The future is brighter than
ever before," admonished C.
Douglas Maynard, M.D.,
invited speaker for the
Twenty-second Annual Wendell G. Scott Memorial Lecture on October 11.
Maynard, president-elect
of the American Board of
Radiology, is a nationally
recognized leader in the
advancement of radiologic
education and has introduced
many innovative approaches
to learning, such as television
programming, research training for residents, and videodisk technology for board
examinations.
He outlined the national
issues facing medical professionals as a result of the
Clinton administration's proposal for health-care reform:
■ a perceived need to
train more primary-care
physicians,
■ the debate on
overspecialization,

■ a requirement for
demonstrated
competence,
■ turf issues between
subspecialty groups,
■ and the need for better
defined quality.
According to Maynard,
who is chairman of the
Department of Radiology at
the Bowman Gray School of
Medicine, these topics are
"causing gentle ripples and
radiology is caught between
the issues."
Accreditation is the
subject of five congressional
bills plus proposals by the
Physician Payment Review
Commission; the Association
of American Medical Colleges; the Council on Graduate Medical Education, the
parent organization for
accreditation; and President
Clinton. Common to all proposals is the recommendation to shift the balance from
specialties to primary care,
limit the number of postgraduate positions, establish
national allocation, and fund
only approved programs.

Nationwide, there are
204 accredited diagnostic
radiology programs with
4,164 positions, and the Residency Review Commission is
recognizing an increase in
diagnostic radiology slots at
the rate of 50 to 60 every six
months. But Maynard predicts that as the U.S. healthcare system is remodeled
over the next five years, radiology faces the potential loss
of a large number of funded
slots.
Evidence of competence and continuing competence also is under review as
there is a need in all specialties for a formal recertification program. The American
College of Radiology's reorganized Task Force on Documenting Continuing
Competence, chaired by
MIR's Bruce L. McClennan,
M.D., is investigating methods for documenting ability
and skill of radiologists, radiation oncologists, and medical physicists.

As one of four recipients of the 1993 MeMn M.
Figley Fellowship in Radiology Journalism, Richard M.
Slone, M.D., recently learned
from the masters the fundamentals of medical journalism. Sponsored by the
American Roentgen Ray
Society (ARRS), the fellowship encourages academic
radiology careers and stimulates interest in high quality
radiology journalism. The
fellowship aims to improve
the quality of radiology publications by teaching journalism skills early in the
academician's career and
providing training for manuscript reviewers and future
editors. After completing
the program, the fellowship
recipients, as core teachers,
can share their skills and
knowledge of medical journalism with colleagues.
At the California-based
editorial offices of the American Journal of Roentgenology (AIR), one of the
nation's leading scientific
publications, Slone received
hands-on-experience in manuscript preparation and editing, the ethics of scientific
jounalism, and the peer
review process. During the
month-long fellowship,
Slone, a clinical instructor
and fellow in chest radiology, also travelled to the
ARRS publication office in
Virginia and to Waverly
Press in Maryland to observe
the mechanics of formatting
and printing the journal.
He is now applying techniques learned from the fellowship program to research
projects, including an analysis of coauthorship in radiology literature and the peer
review process.
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ERL Helps Set
Standard at
RSNA
The Radiological Society
of North America (RSNA)
once again selected the
am: MIR Electronic Radiology
Laboratory (ERL) to develop
triik software for a major demonis stration of digital information
management at the Society's
79th Annual Meeting, NovemI i ber 28 through December 3.
The Digital Imaging and
ijriDD Communication (DICOM)
Standard, completed by the
< fen American College of RadiolK ogy (ACR) and the National
Electrical Manufacturers
Association (NEMA), defines
universal storage and
I'll * exchange of electronic images
fflUlt among the different types of
idiff imaging equipment. A successful demonstration of the
DICOM Standard, involving 20
major manufacturers, was
first featured at the 1992
RSNA Meeting, where MIRdeveloped software supplied
the necessary bridge for
transferring image data
between central test nodes
and each of the manufacturers' demonstration nodes.
Under contract with
RSNA, the team of Stephen M.
Moore, M.S.; David E.
Beecher, M.S.; Sheldon Hoffman, M.S.; G. James Blaine III,
.Sc, director of the ERL; and
R. Gilbert Jost, M.D., director
if the Division of Diagnostic
diology, developed softare to support a much
roader demonstration at
RSNA '93 of image communication among various manufacturers using the DICOM
Standard.
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Software
Developed for
Stereotactic
Radiosurgery
Kanematsu Medical Systems awarded Principal
Investigator Robert E. Drzymala, Ph.D., a one-year contract for $93,500 to develop a
special interactive software
package for simulating and
planning radiotherapy treatment of the brain and for
directing brain biopsies. The
user-friendly system will be
available commercially by
late 1994 and can be used
with digital angiography,
computed tomography (CT),
magnetic resonance (MR),
and positron emission
tomography (PET).
During the scanning
procedures, the patient's
head will be immobilized by
a stereotactic frame. The
frame will show up as dots
on the scans, indicating a
definitive coordinate system.
For 3-D treatment planning,
the coordinate system will
be used to target the radiation beam within one millimeter of the tumor. In
neurosurgery, the system
can provide better visualization for planning brain tissue
biopsies; treating vascular
abnormalities, such as arterial venous malformations
(AVMs); and implanting
devices that assist in chemically or physiologically
manipulating brain tissue.
Coinvestigators for the
project are Joseph R. Simpson, M.D., associate professor of radiology, and Keith
M. Rich, M.D., associate professor of neurological
surgery.

On September 29, friends and colleagues gathered in Scarpellino Auditorium ior the
unveiling oi the official portrait of Carlos A. Perez, M.D., director of the Radiation
Oncology Center. Perez's internationally acclaimed expertise in the field of radiation
oncology earned him the prestigious Gold Medal Award, presented in 1992 by the
American Society for Therapeutic Radiology and Oncology. On hand for the portrait
presentation were (left to right) William H. Danforth, M.D., chancellor of Washington
University; Ronald G. Evens, M.D., director of the Institute; Perez; and Todd H.
Wasserman, M.D., clinical chief of radiation oncology at Jewish Hospital, who spearheaded the commissioning of the portrait.

Moros Receives
Grant
As principal investigator,
Eduardo G. Moros, Ph.D.,
assistant professor of radiology and chief of hyperthermia
physics service, received a
three-year Biomedical Engineering Research Grant from
The Whitaker Foundation to
develop a system that will
more effectively treat small
and large superficial tumors.
Clinical studies have
shown that hyperthermia
(raising the temperature of
tumor tissue to 42-45°C for an
extended length of time) is an
effective adjunct to radiation
therapy, and the simultaneous
delivery of these therapies
provides a more beneficial
method of treatment. Because
of disparity between the therapies and the delivery systems,
including length of treatment
and equipment design, patients
currently receive hyperthermia
before or after radiation.

By integrating ultrasound
technology with a scanning
reflector, the MIR researchers
propose to develop a new
hyperthermia system, specifically designed for simultaneous use with external beam
radiation machines.
Coinvestigators for the
$178,640 grant, "An Ultrasound Array System for
Simultaneous Hyperthermia
and External Beam Radiation
of Superficial Neoplasms,"
include William L. Straube,
M.S., instructor in radiology;
Robert J. Myerson, Ph.D.,
M.D., associate professor of
radiology; Eric E. Klein, M.S.,
instructor in radiology; Daniel
A. Low, Ph.D., instructor in
radiology; and Bahman
Emami, M.D., professor of
radiology and associate director for research - Radiation
Oncology Center.

MIR researchers are using
digital imaging to find a
treatment that reduces the
risk of periodontal bone loss
in postmenopausal women.

womans
>
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Digital imaging technology analyzes periodontal bone loss

Researchers have known for some time that postcranial bone
loss in women is one of the physiological changes that can
accompany menopause. But little is known about the connection between periodontal bone loss and osteoporosis, or why some
"*' * \\-f>

women lose bone more rapidly than others. Variations in periodontal
bone loss patterns among patients first piqued the curiosity of Dr.
Charles F. Hildebolt when he was practicing dentistry. During his nine
years of private practice, Hildebolt saw certain patients who continued
to lose their periodontal bone in spite of dental treatments and good
oral hygiene. He also observed patients who continually had their dentures relined or remade because of the resorption of the alveolar
processes (bony ridges in the upper and lower jaws in which the teeth
are anchored). In some cases those patients underwent surgical ridge
augmentation. Hildebolt wanted to find a method of identifying and
treating those patients at risk. Now as a researcher at Mallinckrodt
Institute of Radiology (MIR), he has received National Institute of Den-

"l

x

tal Research funding for a four-year study on the interrelationships
between alveolar bone loss and postmenopausal osteoporosis.
• by Bridget McDonald

W>man's.
■HEAOH
MM ■ n dental school we were
1 taught that alveolar bone
1 loss could be caused by illfitting dentures, even though it
appeared to be a bigger problem
for women than men. It has also
been suggested that both men and
women lose the same amount of
bone with age, but bone loss in
women is easier to detect because
they have less bone mass initially,"
says Hildebolt, an MIR associate
professor of radiology who carries
both a dentistry degree and a Ph.D.
in physical anthropology.
Clinicians and scientists generally agree that the periodontal alveolar bone resorbs with advancing
age. However, it is not known how
the estrogen therapy some postmenopausal women receive affects
periodontal bone loss, or if the systemic mechanisms responsible for
osteoporosis (bone deterioration in
the postcranial skeleton) cause a
simultaneous loss of periodontal
bone. Hildebolt believes the
causes of periodontal disease, a
common precipitator of tooth loss
and, consequently, also a contributor to ill-fitting dentures in older
women, have not been firmly established, though bacteria in dental
plaque has typically been named
the culprit.

I

The combined disciplines of dentistry and anthropology provide Charles Hildebolt, D.D.S., Ph.D., with a

££ W%y studying one hundred
kpostmenopausal women,
"we are seeking to identify
a group at high risk for periodontal
bone loss, show how they can be
identified early and inexpensively,
and find a treatment that will
reduce the risk for this group,"
explains Hildebolt.

B:

unique multifaceted approach to research.

As principal investigator for
the project, Hildebolt hypothesizes
that the beneficial effects of estrogen therapy for osteoporosis may
also be applied to periodontal bone
loss. The study will quantify bone
loss of the postcranial skeleton and
periodontal bone, while comparing
the rate of bone loss between
women receiving estrogen and
placebo therapies.

By applying NASA's
Landsat technology,
researchers will
analyze digitally enhanced
radiographic images
of the periodontal
bones.

MALLINCKRODT INSTITUTE OF RADIOLOG Y

".. the health of the
peridontal bone may
be shown to be a
sensitive and specific
marker of bone mass
changes."

In order to study periodontal
disease, Hildebolt had to come up
with a way to quantify the rate of
bone loss. That's where coinvestigator Michael Vannier, M.D., professor
of radiology and director of the
Institute's Division of Radiology
Research, has provided a significant
contribution. A former National
Aeronautics and Space Administration (NASA) engineer, Vannier
brings to radiology, through computer and programming support, the
application of digital imaging used
in space exploration.

Left: Hildebolt and research team
members Brent Rice, senior undergraduate
student, and Naoko Yokoyama, data
assistant.
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By applying the digital imaging
process used by NASA's Landsat technology to study the
topographical surfaces of other
planets, researchers at MIR will
analyze digitally-enhanced radiographic images of the periodontal
bone of women participating in the
study. The scanner-based imaging
system provides an enhanced view
of vertical bitewing radiographs,
similar to conventional dental X
rays. These films, which are held
in place in the patient's mouth by
custom-made positioning devices,
go through a special exposure, processing, and digitization procedure.
The end result is a more focused
contrast and edge enhancement of
teeth and bone surfaces than is
found in routine dental radiographs. After the images are
enhanced, precise geometric measurements of the periodontal bone
can be made
The digitized image improves
visualization of the cementoenamel
junction (where the tooth enamel
ends, often below the gumline) and
the alveolar crest (the crest of the
ridge in which the teeth are imbedded). Between these two points
researchers will make six measurements (three on each side of the
tooth - mesial, distal and midtooth), to be automatically stored
in the computer data system and
compared to other sets of measurements taken of the same teeth each
year over a three-year period. In
preliminary studies, the measuring
technique using the digitallyenhanced images proved to be of
submillimeter reproducibility, with
less than .25 millimeter diversion.

W)man's.
■rEACH
■his kind of measurement
technique is very time
intensive,"
i
admits Hildebolt. "But it has a considerable
advantage over traditional methodologies for measuring periodontal
bone loss."
The accuracy in using this
quantitative method is further augmented by taking measurements of
both the facial (outer) and lingual
(inner) crests of the alveolar ridge,
eliminating any chance of undermeasurement of bone loss by looking at only one surface.
In addition to the linear measurements to be analyzed, histograms from each radiograph will
give researchers the opportunity to
compare bone densities in the alveolar ridges. Using the specially
designed computer software to
select a region of interest (ROI) in
a participant's radiographic image,
a baseline of the plot of pixel frequencies or grey scales will be
established for comparison of the
three yearly radiographs. Comparing these histograms will allow
researchers to detect the slightest
change in bone density values.
Additional data will be provided through the use of INTERPROBE'", a pressure-sensitive
electronic periodontal probe.
Using this state-of-the-art computerized probe, a gingival-probingdepth measurement will be made at
six locations per tooth. The distance from the margin of the gums
(gingiva) to the depth of the probe
penetration will be entered directly
into the computer memory, with no
manual entry required. The distance from the cementoenamel
junction to the depth of probe penetration also will be automatically
entered.
//

10

This electronic probe manufactured by Bausch & Lomb

The beneficial
effects of estrogen
therapy for
osteoporosis may
also be applied to
periodontal bone loss.

Oral Care Division provides a computerized method
for documenting periodontal disease.

MALLINCKRODT INSTITUTE OF RADIOLOGY

The illustration depicts the progression of
alveolar bone loss, (left to right) ranging from
normal periodontal support to moderate bone
loss to severe resorption.

I ecause of its unique association with the oral environ'ment, the health of the
periodontal bone may be shown to
be a sensitive and specific marker
of bone mass changes within an
individual," maintains Hildebolt.
"Understanding the relationship
between the bone mineral content
of the postcranial skeleton and the
periodontal bone in postmenopausal women will expand
our knowledge of the menopausal
influence on bone mass and may
also provide an explanation for the
nonperiodontal-disease-related
alveolar bone loss in older
females." □
//

MM ■ f our hypothesis is correct,
\ that alveolar bone densities
I are reduced by systemic
processes in a specific group of
women, it may be that alveolar
bone loss caused by periodontal
disease is exacerbated in these
women," Hildebolt suggests. "Even
though a periodontal pocket does
not necessarily indicate current
disease activity, it is considered to
be a characteristic of past periodontal disease. By comparing
soft-tissue probing measurements
with measurements of the alveolar
bone, we may be able to establish if
a specific group of postmenopausal
women are at high risk of developing periodontal disease."
To investigate how changes in
periodontal bone mass relate to
bone mass changes in other skeletal sites, changes in the height and
density of the periodontal bone will
be compared to changes in bone
mineral content in the spine, forearm, and hip. A correlation matrix
to assess these relationships will be
computed for each yearly interval
and for the overall data collected.

Patients for the research project will be recruited at the Washington University Medical Center
and at the University of Cincinnati
Medical Center. Criteria for inclusion in the study require that the
women have at least 10 measurable
teeth and have ceased menstruation for at least 24 months. They
must also be in good health and
taking no drug treatments (other
than calcium) known to affect bone
metabolism.

B

Bridget McDonald is a free-lance writer,
residing in the St. Louis-area.

Plain film X rays show healthy alveolar bone (left)
and bone loss (right).
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In response to a call from the Society of Nuclear
Medicine (SNM) for proposals on the use of
unsealed sources for radiotherapy, MIR
scientist Carolyn Anderson and a team of
researchers received an SNM fellowship to
compare copper-64 with copper-67.

mmammmmmiMmsmmsimato,
PET RESEARCH SHEDS NEW LIGHT ON PROSTATE CANCER

EWEL
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MAKING

t is said that every man, if he reaches a ripe old age, will have
.some stage of prostate cancer growing within him when he dies.
That's because prostate cancer, which often causes no symptoms, can grow
very slowly, confined to this gland for many years. If this cancer develops in a
man in late life, death usually occurs from other causes, not the cancer.
But every year, growing numbers of men in their forties or fifties are
being diagnosed with the disease. Unfortunately, when prostate cancer develops at this stage of life, it may turn lethal well before a man reaches old age.
The cancer metastasizes to regions outside the prostate capsule before a middle-aged man is even aware he has it.
Within the last 10 years, diagnosing prostate cancer has become easier. Yet every year, nearly 40,000 men die from this disease; fatalities from
prostate cancer are second only to lung cancer. One reason stems from the fact
that conventional checks on the prostate's status — the digital rectal exam and a
blood test known as the PSA (prostate-specific antigen) — are far from definitive.
If one of these tests suggests that something might be amiss, an
ultrasound examination may be performed. Then, information from all these
sources, considered as a whole, suggests whether a tumor is present. But many
men shy away from having a digital rectal exam. What's more, the PSA test is
not widely used. To add to the difficulty, results from a PSA are often imprecise; erroneous conclusions are drawn from about 30 percent of PSA tests.
Thus, the lethal statistics describing the fate of those who have
prostate cancer are likely to persist for the foreseeable future. But at Mallinckrodt Institute of Radiology, there's a jewel in the making that may turn
advanced prostate cancer into a less deadly disease.
by Suzanne Hagan

MAKING

This "jewel" is a tiny, metalbearing protein. Once its
gleam strikes the eye of a
positron emission tomography
(PET) scanner, which assesses biochemical processes and produces
images of function rather than
form, the protein should illuminate
in unimaginable detail certain
tumorous cells originating in the
prostate. These cells that have
spread to other regions of the body
carry receptors for a hormone
called somatostatin.
Using her background as an
inorganic chemist and a radiochemist, Carolyn Anderson, Ph.D.,
and a team of scientists have synthesized what they hope is an
exquisite sensor that signals, via a
three-dimensional PET scanner,
prostate cancer cells studded with
somatostatin receptors. Once
Anderson, an assistant professor in
the Institute's Division of Radiation
Sciences, and the other researchers
find whether prostate cancer cells
display receptors for somatostatin,
they hope that oncologists will be
able to exploit this vulnerability in
diagnosing or treating prostate cancers with somatostatin-like compounds.
Somatostatin was once thought
to be manufactured only in the
brain, where it regulates the production of growth hormone. Now,
it is known that many different
types of cells throughout the body
manufacture this tiny protein.
What's more, many types of tumors
can be treated with somatostatin —
a field that's just beginning to be
explored.
Since somatostatin's existence
is cut short by the body's enzymes,
the natural form of this protein
cannot be used therapeutically.
Sandoz Pharmaceuticals Corporation has manufactured a version of
somatostatin, called octreotide
(Sandostatin R ), that resists biological degradation. Currently, the

Michael Welch, Ph.D., was one of the first researchers
to apply modern organic chemistry to the preparation
of radiopharmaceuticals used in medical imaging.

Tumorous cells in the
prostate that have
spread to other
regions of the body
carry receptors for a
hormone called
somatostatin.

FDA has licensed Sandostatin only
for the treatment of symptoms of
tumors arising in neuroendocrine
tissue or pancreatic islets, says Joel
Picus, M.D., a medical oncologist at
Barnard Cancer Hospital. For
prostate cancers that fail to
respond to conventional treatments, Picus hopes to investigate
whether Sandostatin is effective in
pinpointing somatostatin receptors.
If these receptors are present,
what's the best way to spot them?

MALLINCKRODT INSTITUTE OF RADIOLOGY
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£ £ /"T~1he real technical problem,"
says Michael Welch, Ph.D.,
director of the Division of
Radiation Sciences, "has to do with
the small number of receptors and
the small quantities of octreotide
they'll bind."
Imaging modalities like computed tomography (CT) and magnetic resonance imaging (MRI),
which work well when visualizing
milligram quantities of radiotracers, cannot detect substances like
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"It's now thought that
oncology research is
the future of PET:'
Tammy Pajeau, M.S.

labeled octreotide, which are present in only one-millionth that concentration. Although the PET
scanner is able to detect such small
quantities, costs and chemistry
have gotten in the way of starting
this new line of research.
"Sandostatin is very expensive," points out Anderson. "It costs
about seven hundred dollars for ten
milligrams. What we're hoping to
do is develop a new way of synthesizing octreotide so that we and
other researchers who need to do
solid-phase reactions can have an
inexpensive, convenient source."

Barry Edwards, M.S.
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ying at the base of
the penis, below
JutI the bladder and in
front of the rectum, the
prostate gland depends
upon the male hormone
testosterone to produce
a fluid that is part of
semen. The prostate
surrounds the upper
portion of the urethra, the tube
that empties urine from the
bladder and carries semen
through the penis.
The cause of prostate cancer is unknown, although some
studies suggest that a low-fat
diet may reduce the risk of
developing prostate cancer. In
its early stages, there are often
no symptoms. When symptoms
develop, they may include any
of the following conditions:
■ Blood in the urine
■ Painful or burning
urination
■ Painful ejaculation
■ Inability to urinate
■ Difficulty in starting or
stopping urination
■ Frequent urination,
especially at night
■ Pain in lower back, pelvis,
or upper thighs
These symptoms do not
always signal prostate cancer
but should be checked by a
physician.
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orking with collaborators
Gregg Fields and Cindy
Fields at the University of
Minnesota, Anderson and organic
chemist Barry Edwards are developing a new and simpler version of
octreotide. This synthesis is readily adaptable to preparing
octreotide derivatives for PET
imaging.
The Minnesota team sends a
form of octreotide to the Mallinckrodt Institute researchers, who
then take this unfinished "gem"
through a series of steps. One of
these steps involves attaching a
positron-emitting metal, such as
gallium-68 or copper-64, to
octreotide. Tammy Pajeau, a
senior research technician, then
analyzes the radiolabeled compounds, determining their efficiency in binding to somatostatin
receptors in various types of cells.
If labeled octreotide binds to
somatostatin receptors on prostate
cancer cells, these sites will glow
when viewed with either PET or
single photon emission tomography
(SPECT). Using a PET scanner
that visualizes three dimensions,
researchers can quantify the number of receptors.
£ £ A I ^ en years ago," says Welch,
"no one used PET for
oncology research. Now,
nearly all the work being done on
the current generation of PET scanners is oncology-related. It's now
thought that oncology research is
the future of PET."

T:
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Joel Pkus, M.D., assistant professor of medicine,
is director of the hematology lab, Division of

"This could be a
home run, or we
could strike out."
One of the beauties of using
gallium-68 or copper-64, points out
Welch, is that these isotopes need
not be generated in an accelerator.
For example, copper-64 comes
from the University of Missouri's
Research Reactor. Not using accelerator-generated isotopes brings
down the overall costs.
Another advantage to using
copper-64, says Anderson, is its rel-

Medical Oncology.

atively long half-life (12 hours):
"Researchers can image with copper-sixty-four up to twenty-four
hours as compared to three or four
hours with gallium-sixty-eight.
This allows for better contrast
between the tumor and the rest of
the body."

MALLINCKRODT INSTITUTE OF RADIOLOG ¥

£ £ t I 1 he other reason we're
interested in using coppersixty-four is that it also
has potential as a radiotherapeutic
agent," Anderson adds. "We're
doing some studies now with copper-sixty-four linked to monoclonal
antibodies to study tumor shrinkage, but this approach could also
be used with octreotide."
As promising as this research
is, there are still many unknowns,
advises Picus: "This could be a
home run, or we could strike out."
No one knows whether some,
or any, human prostate cancers
display somatostatin receptors, of
which there are more than one
kind, or what kind of affinity they
would have for octreotide.
"Almost undoubtedly" there will be
subtypes of these receptors, if
there are any at all, on cancer cells,
says Picus. "Our hope is that
octreotide will be active on all subtypes."
Octreotide's usefulness in the
treatment of prostatic cancer may
be only as a staging tool, to discern
information helpful to only 5 to 10
percent of patients. "But even if
only a small percentage of patients
are helped," says Picus, "considering that that's a group of about
forty thousand every year, that's
quite a lot." □

Ti

IMAGING ILLUMINATES NEW WAYS
TO TREAT CANCER
A few years ago, it was discovered that certain breast cancers
grow more fiercely in the presence of estrogen if they have on
their surface a receptor for the hormone. Estrogen that
attaches to its receptor at a tumor cell surface kicks cell reproduction into high gear. If these estrogen receptors are missing, then
something other than estrogen must be the impetus behind the
tumor's growth.
Through the use of radiolabeled estrogens, researchers, aided by
the clinical work of Farrokh Dehdashti, M.D., assistant professor of
radiology, are able to illuminate the hormone's receptors. Once
tumors that have estrogen receptors are differentiated from those
that don't, an oncologist can choose the most effective course of
therapy. Breast cancer cells bearing estrogen receptors on the surface may be crippled by administering therapeutic substances like
tamoxifen.
Tamoxifen mimics estrogen's structure and latches onto the
receptor. Once there, tamoxifen prevents natural estrogens from
attaching. However, the bound tamoxifen — unlike its chemical
cousin estrogen — does not jump-start the cell's cycle of growth.
Thus, the tumor's growth slows or stops.
Using this radiolabeling scheme to pinpoint breast cancer cells
carrying estrogen receptors has engaged Michael Welch, Ph.D.,
director of Mallinckrodt Institute's Division of Radiation Sciences,
for many years. Furthermore, in collaboration with a group at University of Illinois, led by John Katzenellenbogen, Ph.D., Welch
reports that another application of this approach appears to be successful.
Prostatic cancers in animals can be differentiated according to
the presence or absence of androgen receptors, which recognize
testosterone. Now, says Welch, human trials are about to begin, to
see if human prostatic tumors can be differentiated based on the
presence or absence of androgen receptors. If so, then an oncologist
can decide whether use of an anti-androgen will be appropriate therapy.
All of this work has been done using compounds labelled with
non-metals, such as fluorine. But to pinpoint somatostatin receptors
on breast cancer cells, a different approach was needed. New chemical syntheses and methods of protecting functional groups, as well
as affixing metal isotopes, had to be devised. Carolyn Anderson,
Ph.D., and a team of researchers, developed a way to illuminate
these receptors in the PET scanner. "It wasn't simple," says Anderson. "We thought we'd be working with patients a year ago. Now,
we hope to begin clinical trials in 1994."
Suzanne Hagan is a free-lance writer and editor, specializing in
science and medicine.
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the Institute's
new imaging research center
were announced in this year's
spring issue of Focal Spot.
Scheduled for completion in
mid-1994, the facility will be one
of the best equipped centers
worldwide where research
will focus on the development
and application of advanced
imaging systems.
The following is an update

On May 25, the world's first prototype
of a Tandem Cascade Accelerator

of building construction, equipment installation, and faculty
and staff additions.

Since the accelerator's installation,
MIR researchers have been checking the

(TCA) was rolled off a delivery truck

purity of TCA-produced isotopes. The

and installed in the basement of MIR's

TCA will support the imaging center's

East Building. The TCA offers a less

extensive PET research in addition to the

complex alternative to the conventional

clinical and research PET scanners at the

cyclotron-produced radiopharmaceuticals used in PET studies. The collabora-

Washington University Medical Center.
In July, a successful test run pumped

tion of MichaelJ. Welch, Ph.D., director

water and gases through a "rabbit line"

of the Institute's Division of Radiation

to a PET scanner in the medical center.

Sciences, and scientists at an independent research and development company (Science Research Laboratory)
transferred military-related technology
developed under President Reagan's
Star Wars program into a new costeffective accelerator.
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In early September, members of the
Institute's Division of Radiology
Research moved into offices on the
third floor of the East Building, which
were previously occupied by Washington University School of Medicine's Program of Physical Therapy. Under the
leadership of Michael W. Vannier, M.D.,
professor of radiology, the Division
serves as a focus and resource for multiple studies in technology assessment,
clinical protocols, electronic imaging,
Institute's clinical reputation. He pre-

and radiologic procedures. The estab-

E. Mark Haacke, Ph.D., professor of radi-

dicts that in five years significant contri-

lishment of the Division in 1990 indi-

ology, moved into temporary offices on the

butions will be made in brain functional

third floor of the East Building, awaiting

imaging and particularly in MR cardiovas-

cated a major commitment to an
expansion of clinical research projects

completion of the imaging center. These

cular imaging. Haacke believes these

scientists have a broad range of research

technologies will become extremely valu-

at the Institute.
Below, Gulab Bhatia, M.S., instruc-

interests, including brain functional imag-

able tools in clinical application and in

tor in radiology, checks on the housing

ing, high resolution MR angiography, MR

construction for a 3-D body scanner

cardiopulmonary imaging, breast MR, fast

clinical research.
Other MR physicists are Debiao Li,

imaging, general MR physics, and image

Ph.D., assistant professor of radiology;

prostheses.

reconstruction methods.
"The idea of working as a team at the

Weili Lin, Ph.D., assistant professor of

imaging center matches my own philoso-

research associate; Shantanu Kaushikkar,

phy of research," says Haacke, who was

M.S., programmer; James Goldfarb, M.S.,

formerly at Case Western Reserve Uni-

research assistant; Ramesh Venkatesan,

versity in Cleveland. According to

M.S., research assistant; and Song Lai,

Haacke, he was drawn to the imaging

M.S., research assistant.

In August, a group of MR physicists, led by

that will improve procedures for fitting

radiology; Dmitriy Yablonski, Ph.D.,

center because of the top quality 3-D
computer support available, the accessibility of contrast agent expertise, and the
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Looking like a monstrous steel stork
carrying an overgrown bundle, a
construction crane hoisted the 22,000pound Siemens 1.5 Active Shielded
Magnetom almost 60 feet into the air
before depositing it onto a specially
built ramp that led into the MIR's East
Building. A portion of the East Building's wall on the first-floor level had
been removed to accommodate the
magnet's bulk, and workers guided the
magnet through this opening and down
the hall into the MR research area. The
Institute received the magnet in midOctober as part of a new MR scanning
system (Siemen's first and only one
produced to date) that offers higher
internal processing speeds, faster data
acquisition, and larger memory banks
than any other MR scanner now in use.
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Offices and research areas are being
constructed on the second floor of
the East Building to house the neurological PET research faculty and staff,
headed by Marcus E. Raichle, M.D.,
professor of radiology and neurology.
Scheduled to move into their new facilities in early 1994, these PET scientists
have focused their work on normal
brain functions as well as major neurologic and psychiatric disorders. Of
special interest is the functional map-

The future home of Mallinckrodt
Institute's imaging research center,

ping of the brain, especially the areas

at the corner of Scott and Taylor

involved in sensory and language infor-

avenues, was once covered with

mation processing.

asphalt and carried the sole distinction
of "offering the closest parking to the
East Building." Within the past four or
five months, the site was excavated,
foundations were
laid, and steel support girders were
set in place — all
in preparation for
the construction of
a freestanding
structure that will
include four floors
(counting the basement), cover 50,000
square feet, and
house more than
100 faculty and staff
members.

FOCAL SPOT, FALL/WINTER, 1993

21

U

P

D

FYI
THE DIRECTOR'S
OFFICE REPORT
NEW STAFF

OFF STAFF

James W. Debnam, M.D.,
assistant professor of clinical radiology, Division of
Diagnostic Radiology

Clinton M. Anderson,
M.D., instructor in radiology,
completed a four-year residency and a one-year fellowship in magnetic resonance
imaging, and has entered private practice with Colorado
Imaging Association in
Denver.

Menelaos N.
Karamichalis, M.S.,
research assistant in radiology, Division of Diagnostic
Radiology
Peter E. Shile, M.D., assistant professor of radiology,
Division of Diagnostic
Radiology
Robert A. Whitman, M.S.,
research associate in radiology, Division of Diagnostic
Radiology
Nathan C. Nelson, M.S.,
instructor in radiology, Division of Nuclear Medicine
Rupak Kumar Das, Ph.D.,
research associate, Division
of Radiation Oncology
Weihua He, M.S., research
assistant, Division of Radiation Oncology
Assen S. Kirov, Ph.D.,
research associate, Division
of Radiation Oncology
David J. Scherer, M.S.,
instructor in radiology, Division of Radiology Research
Lei Zheng, Ph.D., research
associate, Division of Radiation Sciences

PROMOTIONS
Timothy J. McCarthy,
Ph.D., was promoted to
research instructor in radiology, Division of Radiation
Sciences.

Carlos F. Aquino-Aponte,
M.D., instructor in radiology,
completed a one-year fellowship in magnetic resonance
imaging and has accepted a
position with the Veterans
Administration Hospital in
San Juan, Puerto Rico.
Gregg A. Baran, M.D.,
instructor in radiology,
completed a two-year fellowship in neuroradiology and
has entered private practice
in St. Petersburg, Florida.
Meredith W. Bell, M.D.,
instructor in radiology, completed a one-year fellowship
in abdominal radiology and
has accepted a position in
the Department of Radiology, Duke University Medical Center.
Richard L. Butler, M.D.,
completed one year of training in nuclear medicine and
has entered private practice
in Godfrey, Illinois.
Leeanna Dick, M.D.,
instructor in radiology,
completed a one-year fellowship in vascular and interventional radiology and has
entered private practice
with Durham Radiology
Associates, Durham, North
Carolina.

Gerard M. Eagar, M.D.,
completed one year of training in diagnostic radiology
and has accepted a position
in the Department of Radiology, Taranaki Base Hospital,
New Plymouth, New
Zealand.
Humberto M. Fagundes,
M.D., instructor in radiology
and chief resident, Division
of Radiation Oncology, 19921993, completed a three-year
residency and a one-year fellowship in radiation oncology. He has accepted the
position of head of the
GI/GU radiation section at
Loyola University.
Jeffrey E. Fischbein, M.D.,
instructor in radiology, completed a one-year fellowship
in neuroradiology and has
accepted a position with
Good Samaritan Hospital,
West Palm Beach, Florida.
Robin Frank-Gerszberg,
M.D., instructor in radiology,
completed a one-year fellowship in pediatric radiology
and has entered private practice with the Radiologic
Group of North Jersey,
Wayne, New Jersey.
M. Gena Frederick, M.D.,
completed four years of
training in diagnostic radiology and has received an
abdominal fellowship at
Bowman Gray Medical
Center, Winston-Salem.
Neal A. Frenkel, M.D.,
completed a four-year residency in diagnostic radiology and has received a
cross-sectional imaging/body
imaging fellowship at Jackson Memorial Hospital,
Miami.

Anastasios Georgiou,
M.D., instructor in radiology,
completed a three-year residency and a one-year fellowship in radiation oncology,
and has entered private practice with Jackson/Madison
General Hospital, Jackson,
Tennessee.
Patrick O. Gordon, M.D.,
instructor in radiology, completed a one-year fellowship
in vascular and interventional radiology and has
entered private practice in
Jacksonville, Florida.
Rosalie J. Hagge, M.D.,
completed one year of training in nuclear medicine and
has received an appointment
as resident physician in the
Diagnostic Radiology
Scholar's Program at Duke
University Medical Center.
Dale P. Harris, M.D., completed four years of training
in diagnostic radiology and
has received a body imaging
fellowship at Stanford
University.
Paul S. Hsieh, M.D., completed four years of training
in diagnostic radiology and
has accepted a position in
the Department of Radiology, Cedars-Sinai Medical
Center, Los Angeles.
Edith H. Kang, M.D.,
instructor in radiology and
chief resident, Division of
Diagnostic Radiology, 19911992, completed four years
of training in diagnostic radiology and a one-year fellowship in magnetic resonance
imaging. She has entered
private practice with the
Ramsey Clinic, St. Paul,
Minnesota.
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Karl W. King, M.D.,
instructor in radiology, completed a three-year residency
and a one-year fellowship in
radiation oncology and has
entered private practice with
Radiology Inc., South Bend,
Indiana.
Mark D. Mayhle, M.D.,
instructor in radiology, completed four years of training
in diagnostic radiology and a
one-year fellowship in vascular and interventional radiology. He has entered private
practice with Rock Hill Radiologists, Raytown, Missouri.
Chun Ma, Ph.D., research
associate, Division of Radiation Sciences
Cynthia F. Morrison,
M.D., instructor in radiology,
Division of Diagnostic
Radiology
William A. Murphy, Jr.,
M.D., professor of radiology
and cochief of the musculoskeletal section, has
accepted the position of
chairman of the Division of
Diagnostic Imaging, M.D.
Anderson Cancer Center,
Houston.
Kurt L. Openshaw, M.D.,
instructor in radiology, completed a one-year fellowship
in vascular and interventional radiology and has
entered private practice with
St. Joseph Hospital, Orange,
California.
Nhan P. Truong, M.D.,
instructor in radiology, completed a one-year fellowship
in musculoskeletal radiology
and has accepted a position
at St. Francis Hospital,
Tulsa.
John F. Walsh, M.D., com
pleted a one-year fellowship
in nuclear medicine and has
returned to active duty with
the United States Air Force,
Wilford Hall, San Antonio.
FOCAL SPOT, FALL/WINTER, 1993

Jonathan White, M.D.,
completed six months of
training in nuclear medicine
and has entered private practice with the Maine Medical
Center, Portland.
Mark S. Zobel, M.D., completed four years of training
in diagnostic radiology and
has accepted a position at
Seattle Children's Hospital,
Seattle.

FIRST-YEAR
POSTGRADUATES
Martin M. Anbari, M.D.,
received his Bachelor of Arts
degree in natural science,
medical degree, and law
degree from the University
of Pennsylvania.
H. Scott Beasley, M.D.,
received his Bachelor of Science degree in optometry
and his medical degree from
Indiana University. He is a
member of Alpha Omega
Alpha.
John A. Butman, M.D.,
received his Bachelor of Science degree in applied mathematics and biology from the
California Institute of Technology and his medical
degree from Washington
University.
Dayne D. Hassell, III,
M.D., received his Bachelor
of Arts degree in history and
French from Tulane University and his medical degree
from the University of
Chicago - Pritzker.
John J. Healey, II, M.D.,
received his Bachelor of Arts
degree in biology from
Emory University and his
medical degree from the University of Texas Southwestern Medical School, Dallas.
He is a member of Alpha
Omega Alpha.

Donald V. Heck, M.D.,
received his Bachelor of Science degree in mathematics
from Wake Forest University
and his medical degree from
Duke University. He is a
member of Alpha Omega
Alpha.
David A. Hillier, M.D.,
received his Bachelor of Arts
degree in biology and Bachelor of Science degree in electrical engineering from
Swarthmore College; Doctorate of Science in electrical
engineering from Washington University, Sever Institute of Technology; and
medical degree from Washington University School of
Medicine. He has completed
an internship in internal
medicine at Barnes Hospital,
St. Louis.
William P. James, M.D.,
received his Bachelor of Arts
degree in biology from
Washington University and
his medical degree from University of Missouri School of
Medicine, Columbia.
Debra M. Lau, M.D.,
received her Bachelor of
Arts degree in biology from
Barnard College at Columbia
University and her medical
degree from Albert Einstein
College of Medicine, Yeshiva
University. She is a member
of Alpha Omega Alpha.
Robert C. McKinstry, III,
Ph.D., M.D., received his
Bachelor of Science degree
in electrical engineering
from Boston University, masters degree in nuclear engineering and doctorate
degree in radiological sciences from Massachusetts
Institute of Technology, and
medical degree from Harvard Medical School.

Felix Song, M.D., received
his Bachelor of Science
degree in chemical engineering from the University of
Illinois and his medical
degree from Washington
University.
John E. Sunderland, M.D.,
received his Bachelor of Science degree in medical
dietetics from The Ohio
State University College of
Medicine School of Allied
Medical Professions, masters
degree in nutritional biochemistry from Harvard University, and medical degree
from The Ohio State University College of Medicine. He
is a member of Alpha Omega
Alpha.
Scott A. Werden, M.D.,
received his bachelors
degree in biologic sciences
and his medical degree from
the State University of New
York at Stony Brook. He
completed an internship in
internal medicine at Duke
University Medical Center
and a residency in internal
medicine at Boston City
Hospital. Werden is a member of Alpha Omega Alpha.

NEW FELLOWS
Edward E. C. Angtuaco,
M.D., instructor in radiology,
is a fellow in neuroradiology.
He received his Bachelor of
Science degree in biology
from Ateneo de Manila University, Philippines, and his
medical degree from University of the East Ramon
Magsaysay Memorial Medical Center, Philippines.
Angtuaco completed an
internship and a diagnostic
radiology residency at the
University of Arkansas for
Medical Sciences, Little
Rock. He has received
American Board of Radiology certification.
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continued from page 23
Scott M. Baker, M.D.,
instructor in radiology and
chief resident, Division of
Diagnostic Radiology, 19921993, is a fellow in abdominal imaging. He completed
four years of training in radiology at Mallinckrodt Institute of Radiology. Baker is a
member of Alpha Omega
Alpha.
Clifford D. Barker, M.D.,
instructor in radiology, is a
fellow in magnetic resonance imaging. He received
his Bachelor of Science
degree in mechanical engineering from Cornell University and his medical degree
from New York Medical College. Barker completed an
internship in internal medicine at Waterbury Hospital,
Connecticut, and was chief
resident, diagnostic radiology, 1991-1992, at New York
University Medical Center.
He is a member of Alpha
Omega Alpha.
Benjamin J. Bartnicke,
M.D., instructor in radiology,
is a fellow in abdominal
imaging. He completed four
years of training in radiology
at Mallinckrodt Institute of
Radiology.
Harold F. Bennett, M.D.,
Ph.D., instructor in radiology, is a fellow in abdominal
imaging. He received his
Bachelor of Science degree
in nuclear engineering from
the University of Illinois,
masters degree in nuclear
engineering from the University of Florida, doctorate
degree in nuclear engineering from the University of
Illinois, and medical degree
from the University of Illi24

nois College of Medicine.
Bennett completed an internship at Methodist Hospital,
Indianapolis, and a residency
in diagnostic radiology at the
University of California, San
Francisco. He has received
American Board of Radiology certification.
Marc A. Borge, M.D.,
instructor in radiology, is a
fellow in vascular and interventional radiology. He
received his Bachelor of Arts
degree in biology from Carleton College and his medical degree from the
University of ChicagoPritzker. Borge completed a
residency in diagnostic radiology at the University of
North Carolina Hospitals,
Chapel Hill.
Kun S. Chao, M.D., instructor in radiology, is a fellow in
radiation oncology. He completed two years of residency in radiation oncology
at Mallinckrodt Institute of
Radiology.
John J. Crowley, M.D.,
instructor in radiology, is a
fellow in pediatric radiology.
He received his undergraduate degree from Belvedere
College, Dublin, Ireland, and
his medical degree from
Trinity College, Dublin.
Crowley completed a residency in diagnostic radiology at Allegheny General
Hospital, Pittsburgh.
Patrick D. Datoc, M.D.,
instructor in radiology, is a
fellow in magnetic resonance imaging. He received
his Bachelor of Science
degree in biology from Yale
University and his medical
degree from the Medical College of Virginia. Datoc com-

pleted a residency in radiology at the University of
North Carolina Hospitals,
Chapel Hill. He is a member
of Alpha Omega Alpha and
has received American
Board of Radiology
certification.
Lane A. Deyoe, M.D.,
instructor in radiology, is a
fellow in vascular and interventional radiology. He
completed a one-year fellowship in abdominal imaging at
Mallinckrodt Institute of
Radiology.
David S. Gierada, M.D.,
instructor in radiology, is a
fellow in chest radiology. He
received his Bachelor of Science degree in cell and molecular biology from the
University of Michigan, Ann
Arbor, and his medical
degree from Wayne State
University. Gierada completed an internship in internal medicine/pediatrics at
Strong Memorial Hospital,
Rochester, and a residency
in diagnostic radiology at
Milwaukee County Hospital.
He is a member of Alpha
Omega Alpha and has
received American Board of
Radiology certification.
Carolyn A. Haerr, M.D.,
instructor in radiology, is a
fellow in musculoskeletal
radiology. She received her
Bachelor of Science degree
in Spanish from Creighton
University and her medical
degree from the University
of Nebraska Medical Center.
Haerr completed an internship and a residency in pediatrics at the University of
Colorado Health Sciences
Center, Denver, and a residency in radiology at Denver
Presbyterian Hospital, Denver. She has received American Board of Radiology
certification.

Gregory A. Hatfield, M.D., 1
instructor in radiology, is a
fellow in neuroradiology. He l
received his B.E.E. degree in I
signal processing and biomedical engineering from
the University of Minnesota, I
Institute of Technology; M.S. I
degree in engineering from
the University of California, I
Los Angeles; and medical
degree from the University
of Minnesota Medical
School, Minneapolis. He
completed an internship at
St. Mary's Hospital, San
Francisco, and a residency inl
diagnostic radiology at the
University of Michigan, Ann I
Arbor. Hatfield has received I
American Board of Radiology certification.
Maurice L. King, M.D.,
instructor in radiology, is a
fellow in radiation oncology. I
He completed two years of
residency in radiation oncol-1
ogy at Mallinckrodt Institute I
of Radiology.
Charles T. McConnell,
M.D., instructor in radiology,
is a fellow in neuroradiology.
He received his Bachelor of
Arts degree in chemistry and
zoology from Miami University, Oxford, and his medical
degree from Ohio State University, Columbus. He completed an internship in
internal medicine and a residency in radiology at The
Ohio State University Hospitals. McConnell has received
American Board of Radiology certification.
Timothy R. O'Leary, M.D.,
instructor in radiology, is a
fellow in radiation oncology.
He completed a three-year
residency in radiation oncology at Mallinckrodt Institute
of Radiology.
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Allen B. Oser, M.D.,
instructor in radiology and
cochief resident, Division of
Diagnostic Radiology, 19921993, is a fellow in neuroradiology. He completed a
four-year residency at
Mallinckrodt Institute of
Radiology.
James V. Piephoff, III,
M.D., instructor in radiology
and chief resident, Division
of Radiation Oncology, 19931994, is a fellow in radiation
oncology. He completed a
three-year residency at
Mallinckrodt Institute of
Radiology.
Gregory R. Saboeiro,
M.D., instructor in radiology,
is a fellow in vascular and
interventional radiology. He
received his Bachelor of Science degree in biology from
Washington University and
his medical degree from St.
Louis University School of
Medicine. Saboeiro completed a residency in diagnostic radiology at St. Louis
University Medical Center.
He is a member of Alpha
Omega Alpha and has
received American Board of
Radiology certification.
I Maria E. Schmidt, M.D.,
instructor in radiology, is a
fellow in breast imaging.
She completed three years of
training at Mallinckrodt
Institute of Radiology.
Joseph A. Schoenberger,
IM.D., instructor in radiology, is a fellow in vascular
I and interventional radiology.
I He received his Bachelor of
I Arts degree in chemistry and
i his medical degree from St
Louis University. Schoenberger completed a residency in diagnostic
radiology at the Cleveland
Clinic and has received
i American Board of Radiolj ogy certification.
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Kevin L. Shady, MJJ.,
instructor in radiology, is a
fellow in magnetic resonance imaging. He completed four years of training
in diagnostic radiology at
The Jewish Hospital of St.
Louis.
Richard M. Slone, M.D.,
instructor in radiology, is a
fellow in chest radiology. He
received his Bachelor of Science degree in physics from
Stetson University, Deland,
Florida, and his medical
degree from the University
of Florida, Gainesville.
Slone completed a residency
in radiology at Shands
Hospital, University of
Florida, and has received
American Board of Radiology certification.

DIAGNOSTIC
RADIOLOGY
RESIDENTS
Steven M. Roth, M.D.,
received his undergraduate
degree from the University
of Pittsburgh School of Pharmacy and his medical degree
from Temple University. He
completed an internship in
orthopedic surgery at the
Hospital of University of
Pennsylvania. Roth is a
member of Alpha Omega
Alpha.
Thomas E. Vaughan, M.D.,
received his undergraduate
and medical degrees from
Washington University. He
completed an internship in
internal medicine at
Portsmouth Naval Hospital.
Vaughan is a member of
Alpha Omega Alpha.

Steven S. Winn, MJJ.,
received his undergraduate
degree from McGill University and his medical degree
from Albany Medical College
of Union University. He
completed an internship in
radiology at The Albany
Medical Center. Winn is a
member of Alpha Omega
Alpha.

NUCLEAR
MEDICINE
RESIDENTS
Stephen J. Kennedy, M.D.,
received his Bachelor of Science degree in electrical
engineering and his medical
degree from Ohio State University. He was cochief resident, 1991-1992, diagnostic
radiology, at Shands
Hospital, University of
Florida.
James D. Matthews, M.D.,
received his Bachelor of Science degree in biology and
music from the College of
William and Mary and his
medical degree from the
Medical College of Virginia.
He completed four years of
training in diagnostic radiology at Mallinckrodt Institute.
Matthews is a member of
Alpha Omega Alpha.

Northeast Louisiana University, and medical degree
from Louisiana State University Medical Center. He
completed an internship in
internal medicine at
Louisiana State University
Medical Center and a residency in radiology at the
Medical Center of Virginia.
Vreeland is a member of
Alpha Omega Alpha.

RADIATION
ONCOLOGY
RESIDENTS
Bradley A. Kramer, M.D.,
received his Bachelor of Science degree in chemistry
from Marquette University,
Milwaukee, and his medical
degree from The Medical
College of Wisconsin.
Alfred Tinger, M.D.,
received his undergraduate
degree in physics from State
University of New York at
Binghamton and his medical
degree from State University
of New York - Health Center
at Brooklyn. He is a member
of Alpha Omega Alpha.

Thomas H. Vreeland, M.D.,
received his Bachelor of Science degree in biochemistry
from Louisiana State University, Bachelor of Science
degree in pharmacy from
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VISITING PROFESSORS
& INVITED LECTURERS
Kyongtae Tyler Bae, M.D.,
second-year resident, spoke
on "Automatic Detection of
Pulmonary Nodules in CT
Images" at the National Institutes of Health Research
Festival, Bethesda, September 20 -24.
James A. Brink, M.D.,
assistant professor of radiology, spoke on "Intravenous
Contrast Administration for
Spiral Computed Body
Tomography" at the William
Beaumont Army Medical
Center, El Paso, Texas, September 22.
Carmen S. Dence, M.S.,
research instructor in radiology, presented "The Development of Positron Emitting
Radiopharmaceuticals,"
Shanghai Medical University,
China; "The Recent Developments in Low Energy Accelerators," Chinese Academy
of Sciences, Nuclear
Research Center, Shanghai;
and "PET Research at Washington University," Bering
Normal University, China,
October 30 - November 14.
Bahman Emami, M.D., professor of radiology and associate director for research Radiation Oncology Center,
presented "3D Conformal
Radiotherapy for Bronchogenic Carcinoma: A
Review of State-of-the-Art"
at the IASLC Workshop,
Bruge, Belgium, August 29 September 2.
Louis A. Gilula, M.D., professor of radiology and
director of the musculoskeletal section, presented
refresher courses on "Ankle
Tenosynovitis - Tenography
and MRI" and "Dissociative
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Patterns of the Wrist" at the
20th Annual International
Skeletal Society Meeting,
Toronto, August 15 - 20. He
organized and directed the
International Wrist Investigators' Workshop, September
28, Kansas City, Missouri.
Gilula also displayed an
exhibit on "Tailored Wrist
Instability Series"(coauthored with Nhan Truong,
M.D., St. Francis Hospital,
Tulsa; Frederick Mann,
M.D., University of Washington Medical Center, Seattle;
and Si-Won Kang, M.D.,
visiting physician, Taiwan)
at the American Society for
Surgery of the Hand, Kansas
City, Missouri, September
29 - October 2.
Harvey S. Glazer, M.D.,
associate professor of radiology, spoke on "CT of the
Mediastinum - Differential
Diagnosis," "Pitfalls in Radiologic Evaluation of Bronchogenic Carcinoma," and
"CT of the Bronchi" at Chest
Imaging -1993, Harvard Medical School, Boston, October
18-21.
Jay P. Heiken, M.D., professor of radiology and codirector of computed body
tomography, lectured on
"Spiral CT: Overview and
Technical Considerations,"
"Spiral CT: Applications in
the Abdomen," "Hepatic
Masses: Detection and Characterization with CT and
MRI," and "CT of the Peritoneal Spaces: Anatomy and
Fluid Collections" at Summer Imaging and Interventional Techniques XI,
sponsored by Emory University School of Medicine,
Amelia Island, Florida,
August 2-6. He also spoke

on "MR of the Kidneys and
Adrenals," "MR Evaluation of
Gynecologic Neoplasms," and
"MR of the Liver: Lesion
Detection and Characterization" at Magnetic Resonance
Imaging 1993: Back to the
Future, sponsored by the University of Cincinnati Department of Radiology,
Cincinnati, October 13 -16.
Benjamin C. P. Lee, M.D.,
associate professor, as visiting professor, spoke on "New
Techniques of MR Imaging"
at the Neurological Institute,
Lanzhou Medical Center,
Gansu, China, September
13-16.
Timothy J. McCarthy,
Ph.D., research instructor in
radiology, presented "Recent
Developments in Radiopharmaceutical Production at
Washington University" to
the Faculty Pharmaceutical
Services, Kyushu University,
Fukuoka, Japan, October 18.
Bruce L. McClennan, M.D.,
professor of radiology and
chief of abdominal imaging,
as chairman, organized
"Health Care System Reform:
Opportunities and Exigencies," the Summit Meeting,
Aspen, August 6 - 8. He
spoke on "Diagnostic Imaging
Evaluation of Benign Prostatic Hypertrophy," "Imaging of
Acute Renal Infections,"
"Reactions to Iodinated Contrast Media," "The Retroperitoneum," "Imaging of Renal
and Adrenal Carcinoma," and
"Laparoscopic Urologic
Surgery: What Do Radiologists Need to Know?" at Radiology in Biarritz, France,
September 26 - October 1.
Ali Soleimani-Meigooni,
Ph.D., assistant professor in
radiology, Division of Radiation Oncology, as invited lecturer, spoke on "Quality
Assurance and Clinical Implementation of Pulsed Dose

Rate Remote Afterloading
System," Missouri Valley
Chapter of the American
Association of Physicists in
Medicine Society, October
22 - 23.
Stephen M. Moerlein,
Ph.D., associate professor of
radiology and biochemistry,
as invited lecturer, presented
"Development of Radioligands for PET Study of Brain
Receptors" at the Technical
University of Munich, Germany, July 29. As invited lecturer, he spoke on "Pharmacy
Practice and PET" at the
206th National Meeting of the
American Chemical Society,
Chicago, August 22 - 27.
Moerlein displayed a poster
exhibit, "Comparison of [F18] Benperidol and N-Methyl[F-18] Benperidol as D-2
Receptor-Binding PET Ligands" (coauthored with Joel
S. Perlmutter, M.D., associ-1
ate professor of neurology
and radiology; David
Parkinson, Ph.D., WUMS
assistant professor of cell
biology and physiology; and
Michael J. Welch, Ph.D.,
professor of radiology and
director of the Division of
Radiation Sciences) at the
23rd Annual Meeting of the
Society for Neuroscience,
Washington, D.C., November
7-12.
Eduardo G. Moros, Ph.D.,
assistant professor of radiology and chief of the hyperthermia physics service, as
invited lecturer, presented
"The Simultaneous Delivery
of External Photon/Electron
Beam Radiation and Superficial Microwave/Ultrasound
Ilyperthermia" to the Radiation Oncology Department,
University of California, San
Francisco, September 14.
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James A. Purdy, Ph.D.,
professor of radiology and
associate director of the
Radiation Oncology Center,
presented "Volume and Dose
Specifications: A Prerequisite for QA" at the 1993
American College of Radiology Symposium, "Quality
Assurance of Radiation Therapy Treatment Planning Systems," Washington D.C.,
August 13.
Joseph L. Roti Roti, Ph.D.,
professor of radiology, associate director of the Radiaton Oncology Center, and
chief of the cancer biology
section, spoke on "DNA
Supercoiling, The Nuclear
Matrix and the Response of
Mammalian Cells to Ionizing
Radiation" at the Annual
Meeting of the Japan Radiation Research Society,
Hiroshima, October 28. He
presented "Heat Modified
Nuclear Proteins Associated
with the Nuclear Matrix" at
the Aichi Cancer Center
Research Institute, Nagoya,
Japan, November 1. Roti
Roti lectured on "Role of the
Nuclear Matrix in DNA Organization and Radiosensitivity" to the Department of
Radiation Oncology Faculty
of Medicine, University of
Tokyo, November 2. He also
spoke on "Involvement of
Topoisomerase II in Radiation Induced G2 Delay" at the
Department of Radiation
Research, Tokyo Metropolitan Institute of Medical Science, Tokyo, November 4.
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Henry D. Royal, M.D., professor of radiology and associate director of the Division
of Nuclear Medicine, presented "Chernobyl: Perceptions and Realities," "Effects
of Low Level Radiation: Scientific and Public Views,"
and "Risk Communicaton" at
the Bethesda Naval Medical
Center, Maryland, October
18. As visiting professor, he
spoke on "The International
Chernobyl Project" at the
Joint Program in Nuclear
Medicine, Harvard Medical
School, Boston, October 21.
Royal presented "Health
Care Reform: Scientific
Challenges" and "Chernobyl:
Perceptions and Realities" at
the 26th Annual Meeting of
the New England Chapter,
Society of Nuclear Medicine,
Newport, Rhode Island,
October 22 - 24.
Stuart S. Sagel, M.D., professor of radiology, chief of
chest radiology, and cochief
of computed body tomography, spoke on "CT of the
Pericardium," "High Resolution CT of the Pulmonary
Parenchyma," and "CT of the
Pleura" at the Third Summer
Practicum of the Society of
Computed Body Tomography and Magnetic Resonance
Meeting, Keystone, Colorado, August 15 -19. As visiting professor, he presented
"Spiral CT in the Thorax"
and "CT of Asbestos-related
Thoracic Disease" at the University of Chicago, September 14. Also as visiting
professor, Sagel presented
"CT of Vascular Mediastinal
Lesions;" "CT of the Thorax:
Anatomy, Pitfalls;" and
"Chest Radiology: Low Tech
to High Tech" at Michigan
State University, East
Lansing, November 9.

Barry A. Siegel, M.D., professor of radiology and medicine, and director of the
Division of Nuclear Medicine, as guest lecturer, spoke
on "Radiopharmaceuticals
and the FDA" at the University of Texas, M.D. Anderson
Cancer Center, Houston,
September 28. He also
spoke on "The Scintigraphic
Evaluation of Pulmonary
Embolism" at the Bethesda
Nuclear Medicine Course,
National Naval Medical Center, Bethesda, October 27.
Marilyn J. Siegel, M.D.,
professor of radiology, presented "CT of Congenital
Lung Malformations" and
"CT of the Pediatric Pancreas" at the Third Summer
Practicum of the Society of
Computed Body Tomography and Magnetic Resonance
Meeting, Keystone, Colorado, August 15 -19. She
lectured on "CT/MRI of the
Pediatric Mediastinum" at
the Houston Radiological
Society, Houston, September
27. As visiting professor,
Siegel presented "CT/MR of
the Pediatric Mediastinum"
at the University of Texas
Health Science Center,
Houston, and "Pediatric
Retroperitoneum" at the
Baylor University College of
Medicine, Houston, September 28. She also presented
"CT of the Pediatric Mediastinum," "Imaging of the
Pediatric Kidney," and
"Ultrasonography of the
Acute Abdomen" at the
Michigan Fall Radiology
Conference, Birmingham,
October 16. Siegel spoke on
"Gynecologic and Testicular
Sonography in Children" at
the American Academy of
Pediatrics 1993 Annual Meeting, Washington, D.C., October 29. As a visiting
professor, she lectured on
"Chest Applications of MRI
in Children," "MRI of
Abdominal and Pelvic

Masses in Children," and
"Ultrasonography of Acute
Abdominal Pain in Children"
at the Technion-Israel Institute of Technology, Haifa,
November 9.
Richard M. Slone, M.D.,
clinical instructor in radiology, presented "Chest Radiology" at the University of
California, San Diego,
August 16.
Michael W. Vannier, M.D.,
professor of radiology and
director of the Division of
Radiology Research, presented "Electronic Atlas of
the Human Body" at the
1993 Society of Exploration
Geophysicists Summer
Research Workshop, Rancho
Mirage, California, August 4.
He spoke on "3D Biomedical
Imaging" at Radiology
Grand Rounds, Emory
University Hospital, Atlanta,
September 29.
Michael J. Welch, Ph.D.,
professor of radiology and
director of the Division of
Radiation Sciences, as
invited lecturer, presented
the Special Lecture, "Recent
Advances in Radiopharmaceutical Development and
Applications," at the 33rd
Annual Meeting of the Japanese Society of Nuclear Medicine, Miyazaki, October 29.
Anthony J. Wilson, M.D.,
associate professor and
director of emergency radiology, spoke on "Digital Musculoskeletal Imaging" at the
Refresher Course, 20th
Annual International Skeletal Society Meeting, Toronto,
August 15 - 20.
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SYMPOSIA
AMERICAN
ASSOCIATION OF
PHYSICISTS IN
MEDICINE
The following Mallinckrodt
Institute staff members participated in the 35th Annual
Meeting and Technical
Exhibition of the American
Association of Physicists in
Medicine, Washington, D.C.,
August 8 - 12.
PROFESSIONAL
COUNCIL
SYMPOSIUM
James A. Purdy, Ph.D.,
"Standards for Radiation
Oncology Physics"

YOUNG
INVESTIGATORS'
SYMPOSIUM
Vivek Mishra, Ph.D.; Jeffrey F. Williamson, Ph.D.;
Zuofeng Li, D.Sc; Ali
Soleimani-Meigooni,
Ph.D.; "RadioChromic Film
Densitometry for High Dose
Rate Ir-192 Dosimetry:
Accuracy and Precision"

SCIENTIFIC
PROGRAMS
Program 2
Eric E. Klein, M.S.; Daniel
A. Low, Ph.D.; Christopher Durbin, Ph.D.; James
A. Purdy, Ph.D., "Changes
in Electron Beam Dosimetry
with the New Scattering FoilApplicator Systems on a
C12100C"
Eric E. Klein, M.S.; Daniel
A. Low, Ph.D.; Christopher Durbin, Ph.D.; Ali
Soleimani-Meigooni,
Ph.D.; James A. Purdy,
Ph.D., "Dosimetry for Clinical Implementation of
Dynamic Wedge on a
C12100C"
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Program 3
Ali Soleimani-Meigooni,
Ph.D.; Harish Panth,
Ph.D.*; Vivek Mishra,
Ph.D.; Jeffrey F.
Williamson, Ph.D., "Dependence of Linearity, Accuracy,
and Low-Dose Limit of TLD
Response on Nitrogen Flow
in the TLD Reader." *Best
Medical International,
Springfield, Virginia
Ali Soleimani-Meigooni,
Ph.D.; Eric E. Klein, M.S.;
Christopher Durbin,
Ph.D.; James A. Purdy,
Ph.D., "Tissue Interface
Measurements with
GafChromic Film"
Program 4
Ali Soleimani-Meigooni,
Ph.D.; Eric E. Klein, M.S.;
Vivek Mishra, Ph.D.;
Daniel A. Low, Ph.D.;
James A. Purdy, Ph.D.,
"GafChromic Film Dosimetry
for Megavoltage X-ray
Beams"
Robert E. Drzymala,
Ph.D.; Prithvi Narayan,
M.S.*; Timothy R. O'Leary,
M.D.; Keith M. Rich, M.D.*;
Joseph R. Simpson, M.D.;
Todd H. Wasserman, M.D.;
William B. Harms, B.S.;
John W. Matthews, D.Sc;
James A. Purdy, Ph.D., "A
Computerized Treatment
Planning System for Stereotactic Radiosurgery."
♦Department of Neurological
Surgery, Washington University, St. Louis
Program 5
Robert E. Drzymala,
Ph.D.; Prithvi Narayan,
M.S.*; Keith M. Rich,
M.D.*, "A Computerized System for Image-Based Planning of Stereotactic Brain
Biopsies." *Department of
Neurological Surgery, Washington University, St. Louis

Walter R. Bosch, D.Sc;
Daniel A. Low, Ph.D.; Russell L. Gerber, M.S.; Mary
L. Vogelsang Graham,
M.D.; Jeff M. Michalski,
M.D.; Carlos A. Perez,
M.D.; James A. Purdy,
Ph.D., "An Electronic View
Box Tool for Radiaton Therapy Treatment Verification"
Daniel A. Low, Ph.D.; Eric
E. Klein, M.S.; Derek K.
Maag, electronic technician; James A. Purdy,
Ph.D., "The Commissioning
of a Varian PortalVision™
Electronic Portal Imaging
Device"
Program 6
Zuofeng Li, D.Sc; Ali
Soleimani-Meigooni,
Ph.D.; Vivek Mishra, Ph.D.,
"A Comparative Study of
Dosimetric Properties of
Solid Water and Plastic
Water in Brachytherapy
Applications"
Zuofeng Li, D.Sc; Jeffrey
F. Williamson, Ph.D.;
Harold Perera, Ph.D.,
"Monte Carlo Calculation of
Kerma-to-a-Point Near Media
Interfaces"
Jeffrey F. Williamson,
Ph.D., Zuofeng Li, D.Sc;
Perry W. Grigsby, M.D.;
"Monte Carlo Aided Dosimetry of the MicroSelection
PDR Source and Shielded
Fletcher Colpostat"
Jeffrey F. Williamson,
Ph.D.; Ali Soleimani-Meigooni, Ph.D.; Perry W.
Grigsby, M.D.; Steven
Teague*, "Acceptance Testing of a Novel Single-Stepping Source Remote
Afterloader for Low DoseRate Brachytherapy: A Systematic Approach."
*Nucletron Corporation,
Columbia, Maryland

Program 7
Jeffrey F. Williamson,
Ph.D., cochairman
Eduardo G. Moros, Ph.D.;
Eric E. Klein, M.S.;
William Straube, M.S.;
Robert J. Myerson, M.D.,
"Clinical Systems for Simultaneous Superficial Hyperthermia and External Beam
Radiation"
Program 8
Y. Abel Cheng, M.S.;
William B. Harms, B.S.;
Russell L. Gerber, M.S.;
John W. Wong, Ph.D.*;
James A. Purdy, Ph.D., "A
Systematic Verification of a
3-D Electron Beam Dose Calculation Algorithm."
*Department of Radiation
Oncology, William Beaumont
Hospital, Royal Oak,
Michigan
Program 9
Eric E. Klein, M.S.; James
A. Purdy, Ph.D., "A Com
prehensive Dosimetric and
Continuing Quality Improvement Program for a 50 kVp
Endocavitary Unit"

SCIENTIFIC
PAPER ABSTRACTS
Nilesh L. Jain, M.S.;
Michael G. Kahn, M.D.*;
James A. Purdy, Ph.D.; "A
Decision-theoretic Model for
the Objective Evaluation of
3D Radiation Treatment
Plans." *Department of
Internal Medicine, Washington University, St. Louis
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INTERNATIONAL
SYMPOSIUM
ON RADIOPHARMACEUTICAL
CHEMISTRY
The following Mallinckrodt
Institute staff members participated in the Tenth International Symposium on
Radiopharmaceutical
Chemistry, Kyoto, Japan,
October 25 - 28.

SESSION IL
TECHNETIUM
RADIOPHARMACEUTICALS
Oral Presentation
Dal Y. Chi, Ph.D.*; James
P. O'Neil, Ph.D.*; Carolyn
J. Anderson, Ph.D.;
Michael J. Welch, Ph.D.;
John A. Katzenellenbogen, Ph.D.*, "Novel Homoand Heterodimeric Bisbidentate (NS) Technetium(V) Complexes. An
Approach to Metal Complexes that Mimic Steroid
Hormones." '"Department of
Chemistry, University of Illinois, Urbana

SESSION IIL
POSITRONS
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Oral Presentation
Timothy J. McCarthy,
Ph.D.; Thomas A.
Bonasera, M.S.; Michael J.
Welch, Ph.D.; Shlomo
Rozen, Ph.D.*, "Application
of Methyl Hypofluorite
Chemistry: Synthesis of
Novel Steroidal Substrates
and Labeling with C-ll."
*School of Chemistry, TelAviv University, Israel
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Poster Presentation
Carmen S. Dence, M.S.;
Christy S. John, Ph.D.;
Michael J. Welch, Ph.D.,
"The Combined Use of
Microwave Heating and Photolysis in the Synthesis of
[18F]-substituted Benzamides"

SESSION

V:

RADIOISOTOPE
PRODUCTION
Oral Presentation
Carmen S. Dence, M.S.;
Michael J. Welch, Ph.D.;
Barbara J. Hughey, Ph.D.*;
Robert E. Klinkowstein,
Ph.D.*; Ruth E. Shefer,
Ph.D.*, "A New Method of
Nitrogen-13 Ammonia Production Applicable with Low
Energy Accelerator." *Science Research Laboratory,
Somerville, Massachusetts

SESSION VIL
PEPTIDES, PROTEINS
AND ANTIBODIES
Oral Presentation
Michael J. Welch, Ph.D.,
chairman
Carolyn J. Anderson,
Ph.D.; Buck E. Rogers,
M.S.; Judith M. Connett,
Ph.D.*; Li W. Guo, Ph.D.;
Sally W. Schwarz, R. Ph.,
M.S.; Kurt R. Zinn, D.V.M.,
Ph.D.**; Michael J. Welch,
Ph.D., "Comparison of Two
Bifunctional Chelates for
Labeling 64 Cu to Mab 1A3
and 1A3-F(ab')2: Chemistry
and Animal Biodistribution."
'"Department of Surgery,
Washington University, St.
Louis. **Research Reactor,
University of Missouri,
Columbia

Poster Presentations
Wilson B. Edwards, M.S.;
Carolyn J. Anderson,
Ph.D.; Michael J. Welch,
Ph.D.; Cynthia G. Fields,
M.S.*, "The Synthesis of
DTPA-D-Phe1_octreotide by
Solid-phase Synthesis."
♦Department of Biomedical
Engineering, University of
Minnesota
Carolyn J. Anderson,
Ph.D.; Wilson B. Edwards,
M.S.; Tammy S. Pajeau,
M.S.; Buck E. Rogers,
M.S.; Kurt R. Zinn, D.V.M.,
Ph.D.*; Henry V. Lee, B.A.;
Michael J. Welch, Ph.D.,
"In vitro and in vivo Evaluation of [64 Cu-CPTA-D-Phe1]octreotide: An Agent for
Quantitating Somatostatin
Receptors with PET."
♦Research Reactor, University of Missouri, Columbia

SESSION viii: RADIOPHARMACEUTICALS
FOR NEUROTRANSMISSION
Poster Presentation
Stephen M. Moerlein,
Ph.D.; Joel S. Perlmutter,
M.D.; James L. Bockhorst,
B.S.; David Parkinson,
Ph.D.*; Michael J. Welch,
Ph.D., "N-Alkylated Analogues of [F-18]Benperidol
as Dopaminergic D-2 Receptor Ligands." '"Department
of Cell Biology and Physiology, Washington University,
St. Louis

SESSION IX:
MISCELLANEOUS
Oral Presentation
Timothy J. McCarthy,
Ph.D.; Michael J. Welch,
Ph.D.; Jian Zhang, M.S.,
"Nitric Oxide Synthase
(NOS): Approaches to the
Design and Synthesis of
Inhibitors of this Enzyme
Suitable for Radiolabeling
and Measurement of in vivo
Biodistribution"
Poster Presentations
Carolyn J. Anderson,
Ph.D.; Christy S. John,
Ph.D.*; Robert K. Keast,
CNMT; Henry V. Lee, B.A.;
Michael J. Welch, Ph.D.,
"N,N'-Ethylene-di-L-cysteine:
A Potential Ligand for Gallium and Indium Radiopharmaceuticals." '"Department
of Radiology, George Washington University, Washington, D.C.
Sally W. Schwarz, R.Ph.,
M.S.; John O. Eichling,
Ph.D.; Michael J. Welch,
Ph.D., "Considerations
Necessary for Determining
Radiation Dosimetry of
Positron Emitting
Radiopharmaceuticals

HONORS'
AMBDS
Barry A. Siegel, M.D., professor of radiology and medicine, and director of the
Division of Nuclear Medicine, is president of the
Washington University Medical Center Alumni Association (WUMCAA). He earned
both his undergraduate and
medical degrees at Washington University and has been
an MIR faculty member and
director of the Division of
Nuclear Medicine since
1973.
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APPOINTMENTS/
ELECTIONS
Jeffrey J. Brown, M.D.,
associate professor of radiology and chief of the magnetic
resonance imaging section,
was appointed director of the
research residency at the
Institute.
Mary L. Vogelsang Graham,
M.D., instructor in radiology,
was appointed to the 19931994 Committee on Admissions, Washington University
School of Medicine.
Daniel A. Low, Ph.D.,
instructor in radiology, was
appointed to full membership
in the American Association
of Physicists in Medicine.
Bruce L. McClennan, M.D.,
professor of radiology and
chief of the abdominal imaging section, will serve a two-

year term as the elected faculty representative to the
Department of Radiology,
Executive Committee.
Ali Soleimani-Meigooni,
Ph.D., assistant professor of
radiology, was selected president-elect (1993-1994) of the
Missouri Valley Chapter of
the American Association of
Physicists in Medicine.
Michael W. Vannier, M.D.,
professor of radiology and
director of the Division of
Radiology Research, was
named chairman of the Missouri State Medical Association's 1993-1994 Commission
on Continuing Education and
Health Manpower.

ALUMNI NEWS
When Phyllis Isbell, R.T., retired after 38 years at the Washington University Medi
Center, (left to right) doctors Jerry Palagallo, MIR 74; Art Bishop, '81; Tom Getz,
'87; and Bill Berkman, 79, couldn't make it to the retirement party. So, the fourso
from Methodist Medical Center of Illinois in Peoria donned fluoro gear and had this
special photograph made for Phyllis' memory book.

Residents, trainees, and fellows for 1992-1993 were (front row, left to right) Doctors Neda Yagon; L. Santiago Medina; Colin P. Derdeyn; Scott M. Baker, chief resident;
Ronald G. Evens, director of the Institute; Allen B. Oser, cochief resident; James R. Duncan; Neal A. Frenkel; Jeffrey A. Friedland; Andrew J. Fisher; Mary G. Alderman; (second
row, left to right) Eric R. Weidman; Michele D. Semin; Kyongtae Tyler Bae; Valerie Christy Rekhert; Lane A. Deyoe; Paul S. Hsieh; Maria E. Schmidt; Cynthia Karfias-Rigsby;
Anthony M. Foti; Matthew J. Fleishman; Richard N. Edelstein; (third row, left to right) Michael C. Roarke; Eric S. Maiden; Howard P. Forman; Meredith W. Bell; Robin FrankGersiberg; Spencer M. Smith; Benjamin J. Bartnicke; Hamid R. Lotifi; Shawn P. Quillin; Farrel K. VanWagenen; (back row, left to right) Chi-Lai Ho; Rosalie J. Hagge; Francis J.
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REFLECTIONS
by Henry D. Royal, M.D.

COST CONTAINMENT AND
TECHNOLOGY ASSESSMENT:
SCIENTIFIC CHALLENGES
The cost of medical care has
increased at a rate greater than
the increase in the gross national
product of the United States. Until
now, medicine has been relatively
immune to cost considerations. At
some point, strenuous efforts to contain costs will necessarily be made
and will be shaped by social, political
and scientific forces. This review
will discuss technology assessment
and the scientific challenges that
need to be addressed in an era of
cost containment.
Concerns about costs have
increased the demand for scientific
evidence to show that a diagnostic
test (as well as therapeutic interventions) benefits patients in some
meaningful way. In the past, technology assessment focused on diagnostic accuracy. In the future,
technology assessment will be
focused on whether or not use of
the technology improves patient
outcome.
The Agency for Health Care Policy and Research (AHCPR) is a new
federal agency created to encourage
patient outcome research. The
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AHCPR was instrumental in the
development of "Practice Guidelines"
that recommend how to best manage
patients with various diseases.
TECHNOLOGY ASSESSMENT

Technology assessment is one of
many factors considered when
developing a practice guideline and
can focus on many different levels of
efficacy (Table 1). These levels of
efficacy have a natural hierarchy.
Demonstration that a technology is
"better" at a lower level of efficacy is
a necessary but insufficient requirement to demonstrate that the technology is "better" at a higher level of
efficacy.
The lowest level of efficacy measures the technical characteristics of
the technology. For example, one
type of computed tomography (CT)
scanner may have better spatial resolution that another type of CT
scanner. This technical advantage
does not necessarily translate into
better diagnostic accuracy, better
patient management, or better
patient outcome.
The next higher level of efficacy
measures diagnostic accuracy. The
most rudimentary study of diagnostic
accuracy describes the findings in
patients with a known disease as
compared to
the findings
Table 1
of "normal"
Levels of Efficacy
patients.
This initial
Example
Level
assessment
Spatial Resolution
1. Technical Characteristics
simply deter2. Diagnostic Accuracy
Findings in normals/abnormals
Descriptive
whether or
not further
Sensitivity/specificity
Quantitative
assessment
ROC Curve
of the techLikelihood Ratio
nology
Post-test probability
3. Diagnostic Certainty
should be
Treatment changed because
pursued.
4. Patient Management
of test result
Unfortunately, these
Patient outcome changed
5. Patient Outcome
preliminary
due to change in treatment
assessments
Cost/Benefit
6. Societal Outcome
are often
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misconstrued as indicating that the
technology is clinically useful.
The accuracy of a test in differentiating normal from abnormal
patients is expressed traditionally as
the sensitivity and specificity. Unlike
overall accuracy, these measures are
independent of disease prevalence
and, therefore, are a better measure
of diagnostic accuracy. Despite their
widespread use, sensitivity and
specificity have a number of glaring
deficiencies. First, the researcher is
forced to reduce the results of a
complex imaging test that displays
many features to a binary result (normal or abnormal). This data reduction makes subsequent data analysis
much simpler; however, the obvious
drawback is that significant information from the test is ignored.
Second, the disease status of the
patient also is reduced to a binary
result. This oversimplification does
not permit evaluation of test performance with disease severity. In addition, disease status is often
determined by another imperfect test
and does not necessarily represent
the true disease status of the patient.
Third, sensitivity and specificity
rarely are reported with 95 percent
confidence intervals. This omission
hides the fact that sensitivity and
specificity measurements often are
inexact simply due to the small number of subjects used to measure
these two parameters.
Receiver operator characteristic
(ROC) curves address some of the
deficiencies of sensitivity and specificity. These curves traditionally
classify the test result in one of five
categories: definitely normal, probably normal, possibly abnormal, probably abnormal, and definitely
abnormal. Four sensitivity, specificity pairs can be created by using a
different threshold for distinguishing
normal from abnormal test results.
For example, a strict threshold
would require that the test result be
classified as "definitely abnormal" in
order to be considered "abnormal,"
31
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■ much greater than
1.0 (the feature is much
Calculation of Likelihood Ratios
more common in patients
Probability of a Test Feature
with the disease than
vs Disease Status
without the disease), the
feature greatly increases
D+
DLR
the chances that the
1
T
.5
.005
100
patient has the disease;
(0.5/.005)
■ equal to one, that
2
T
.25
.025
10
test
feature does not help
(.25/.025)
3
distinguish patients with
.1
.1
.1
and without the disease
(.l/.l)
rp4
of interest;
.01
.1
.1
(.01/. 1)
■ much less than one,
that test feature is useful
for excluding the disease.
Tn = Individual Test Feature
When test features
D+ = Disease Population
are listed with their likeliD- = Nondisease Population
hood ratios, it becomes
LR = Likelihood Ratio
very apparent which
features of an image
have the most diagnostic value.
resulting in the lowest sensitivity but
The likelihood ratios can be deterthe highest specificity. On the other
mined not only for the individual test
hand, a lax threshold would classify
features but also for combinations
all test results other than "definitely
of test features.
normal" as "abnormal," resulting in
the highest sensitivity but the lowest
SCIENTIFIC CHALLENGES
specificity. Typically, the ROC curve
is plotted as the sensitivity versus
In order to improve the cost-effecone minus the specificity. As test
tive use of diagnostic tests, the
performance improves, the curve is
emphasis of technology assessment
shifted upward and to the left.
must change. Multicenter studies to
The final, and probably the best,
determine how a diagnostic test
way to express the diagnostic accuchanges patient outcomes will be
racy of a complex test is likelihood
necessary. For example, patients
ratios. A detailed list of the potential
may be randomized into one group of
features in an image is generated,
patients having the diagnostic test
e.g., the size of a lung nodule,
and another group not having the
whether its borders are smooth or ill
diagnostic test. Measures of morbiddefined, whether it is calcified, etc.
ity, mortality, patient preferences and
How often these features are present
satisfaction would be obtained in
in the disease of interest (e.g., maligeach group to determine the impact
nant lung tumors) is compared to an
of introducing the new test.
appropriate "non-disease" group
In the past we have measured the
(patients with benign lung nodules)
efficacy of a test, in the future we will
(Table 2). The likelihood ratio is calmeasure the effectiveness of the test.
culated simply by dividing the probaEfficacy is measured by using a
bility of finding that particular test
homogeneous well-defined patient
feature in patients with disease by
population; the test is performed and
the probability of finding that identiinterpreted in an ideal setting by
cal test feature in patients without
experts in the field. Effectiveness
the disease. If the likelihood ratio for would determine how well the test
a particular test feature is
performs in a more realistic clinical
setting. The impact of the test would
Table 2
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be determined in multiple medical
centers to determine if the performance of the test is greatly reduced
in a more realistic clinical setting.
The development of more sensitive diagnostic tests may lead to
some unexpected problems. First,
the prognostic value of a test may
decrease because everyone with the
disease now has a positive test
rather than just the most severely
affected. Second, the apparent
prevalence of disease increases. A
good example of this problem is
prostate cancer. Since clinically
occult and insignificant disease is
common, better diagnostic tests will
increase the apparent prevalence of
this disease. Third, the diagnosis of
clinically insignificant disease will
falsely increase our perceptions of
the apparent efficacy of treatment.
Patients whose disease would never
have harmed them will now be
regarded as cures.
The demand that medicine be
more scientific and evidence-based
is laudable. In the future, it will be
a challenge to maintain the appropriate balance between the science
and art of medicine. Scientists are
better able to accumulate scientific
evidence than are physicians. In
order to understand pathophysiologic mechanisms, scientists can
study inbred animals (in order to
minimize confounding variables)
and they can perform interventions
that would be unethical in humans.
Because of the limitations imposed
when studying human disease, we
must accept the fact that the science of medicine will always be
flawed. If the demand for scientific
evidence in medicine is too great,
innovation will be greatly slowed
and future patients will suffer. □
Dr. Royal is professor of radiology and
associate director of the Division of
Nuclear Medicine. This article originally appeared in the September issue
of MIR Update, a physician newsletter
distributed quarterly by the Institute.
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As the guest of
Washington University
and Friends of Tibet,
the 14th Dalai Lama
of Tibet, His Holiness
Tenzin Gyatso, was in
St. Louis in September.
His Holiness made a
special visit to the
Institute's seventhfloor positron emission
tomography (PET) facility
to learn more about the
work of Marcus E. Raichle,
M.D., professor of radiology and neurology and
head of neurological PET
research.
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